{
    "title": "U.S. FDA gives broader approval to GSK's Zejula for ovarian cancer",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8270957/U-S-FDA-gives-broader-approval-GSKs-Zejula-ovarian-cancer.html",
    "date": "2020-04-29",
    "keywords": [
        "cancer",
        "drug",
        "use",
        "zejula",
        "maintenance",
        "parp",
        "therapy",
        "approval",
        "class",
        "research",
        "drugmaker",
        "time",
        "food",
        "administration",
        "glaxosmithkline",
        "plcs",
        "option",
        "bay",
        "population",
        "opportunity",
        "dna",
        "focus",
        "breast",
        "lung",
        "prostate",
        "inhibitor",
        "mutation",
        "brca",
        "enzyme",
        "duration",
        "nod",
        "compete",
        "merck",
        "amp",
        "cos",
        "lynparza",
        "clovis",
        "oncologys",
        "rubraca",
        "recurrent",
        "treatment",
        "chemotherapy",
        "course",
        "disease",
        "win",
        "strategy",
        "purchase",
        "tesaro",
        "inc",
        "potential",
        "head",
        "officer",
        "hal",
        "barron",
        "chief",
        "executive",
        "emma",
        "oncology",
        "growth",
        "loss",
        "patent",
        "protection",
        "profit",
        "beat",
        "demand",
        "blockbuster",
        "vaccine",
        "pain",
        "relief",
        "coronavirus",
        "reporting",
        "carl",
        "odonnell",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}